Company news

Amphastar Pharmaceuticals, Inc. news in 2026

Amphastar Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026

October 29, 2026

Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference

September 1, 2026

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

August 6, 2026

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

July 29, 2026

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

May 26, 2026

Q1 Financial Results (news)

May 8, 2026

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

May 6, 2026

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

May 6, 2026

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

April 30, 2026

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

April 6, 2026

Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference

March 4, 2026

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025

February 26, 2026

Amphastar Announces FDA Approval for Ipratropium Bromide HFA

February 23, 2026

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026

February 19, 2026

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

January 11, 2026

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

January 6, 2026

Calls in 2026

Decks in 2026